Log in

CTD News Headlines (OTCMKTS:CTDH)

$0.18
+0.02 (+12.20 %)
(As of 02/27/2020 08:57 AM ET)
Today's Range
$0.17
Now: $0.18
$0.19
50-Day Range
$0.17
MA: $0.20
$0.29
52-Week Range
$0.13
Now: $0.18
$0.84
Volume45,623 shs
Average Volume145,737 shs
Market Capitalization$22.39 million
P/E RatioN/A
Dividend YieldN/A
Beta0.56

Headlines

CTD (OTCMKTS CTDH) News Headlines

Source:
DateHeadline
Cyclo Therapeutics Announces Completion of Enrollment in its Extension Protocol to the Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type CCyclo Therapeutics Announces Completion of Enrollment in its Extension Protocol to the Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
finance.yahoo.com - February 26 at 8:40 AM
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I/II Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type CCyclo Therapeutics Announces Completion of Enrollment in its Phase I/II Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
finance.yahoo.com - February 20 at 8:42 AM
Last Patient Last Visit in Cyclo Therapeutics’ Phase I Trial in Niemann-Pick Type CLast Patient Last Visit in Cyclo Therapeutics’ Phase I Trial in Niemann-Pick Type C
finance.yahoo.com - February 11 at 9:20 AM
Cyclo Therapeutics, Inc. Poster Presentation of Clinical Trial Data on Niemann-Pick Type C Disease at the 16th Annual WORLDSymposium Now AvailableCyclo Therapeutics, Inc. Poster Presentation of Clinical Trial Data on Niemann-Pick Type C Disease at the 16th Annual WORLDSymposium Now Available
finance.yahoo.com - February 5 at 11:39 AM
Cyclo Therapeutics to Present at BIOTECH SHOWCASE™ 2020 in San FranciscoCyclo Therapeutics to Present at BIOTECH SHOWCASE™ 2020 in San Francisco
finance.yahoo.com - January 7 at 5:22 PM
Cyclo Therapeutics Signs Master Services Agreement with Worldwide Clinical TrialsCyclo Therapeutics Signs Master Services Agreement with Worldwide Clinical Trials
finance.yahoo.com - December 27 at 9:15 AM
Cyclo Therapeutics Receives Buy Recommendation and $1.25 Price Target from ThinkEquityCyclo Therapeutics Receives Buy Recommendation and $1.25 Price Target from ThinkEquity
finance.yahoo.com - December 18 at 7:17 AM
Cyclo Therapeutics, Inc. to Present Clinical Trial Data on Niemann-Pick type C Disease at the 16th Annual WORLDSymposiumCyclo Therapeutics, Inc. to Present Clinical Trial Data on Niemann-Pick type C Disease at the 16th Annual WORLDSymposium
finance.yahoo.com - December 16 at 8:29 AM
Cyclo Therapeutics’ Chief Scientific Officer Appointed to President’s Council of Advisors on Science and TechnologyCyclo Therapeutics’ Chief Scientific Officer Appointed to President’s Council of Advisors on Science and Technology
finance.yahoo.com - December 10 at 8:59 AM
Cyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Pivotal Trial in Niemann-Pick Disease Type CCyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Pivotal Trial in Niemann-Pick Disease Type C
finance.yahoo.com - November 8 at 9:14 AM
Cyclo Therapeutics Announces Its Publication of the Most Extensive Set of Case Study Reports To-Date on Expanded Access Use of Hydroxypropyl Beta Cyclodextrin in Niemann-Pick Disease Type CCyclo Therapeutics Announces Its Publication of the Most Extensive Set of Case Study Reports To-Date on Expanded Access Use of Hydroxypropyl Beta Cyclodextrin in Niemann-Pick Disease Type C
finance.yahoo.com - October 31 at 9:58 AM
Cyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Alzheimer’s Disease Clinical TrialCyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Alzheimer’s Disease Clinical Trial
finance.yahoo.com - October 30 at 12:14 PM
Cyclo Therapeutics Prepares for Alzheimer’s Development Program After Success with First PatientCyclo Therapeutics Prepares for Alzheimer’s Development Program After Success with First Patient
finance.yahoo.com - October 28 at 7:26 AM
Cyclo Therapeutics, Inc. Chief Scientific Officer, Sharon H. Hrynkow, Ph.D., Appointed to President’s Council on Science and TechnologyCyclo Therapeutics, Inc. Chief Scientific Officer, Sharon H. Hrynkow, Ph.D., Appointed to President’s Council on Science and Technology
finance.yahoo.com - October 23 at 10:59 AM
Cyclo Reports Progress in NPC DrugCyclo Reports Progress in NPC Drug
www.baystreet.ca - October 22 at 3:40 PM
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type CCyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
finance.yahoo.com - October 22 at 10:40 AM
Cyclo Therapeutics Announces Its Support for The Firefly Fund’s Newborn Screening ProgramCyclo Therapeutics Announces Its Support for The Firefly Fund’s Newborn Screening Program
finance.yahoo.com - October 18 at 12:18 PM
Cyclo Therapeutics, Inc. Announces Maurizio Scarpa, MD as EU Coordinating Investigator for the Company’s Pivotal Trial in Niemann-Pick Disease Type CCyclo Therapeutics, Inc. Announces Maurizio Scarpa, MD as EU Coordinating Investigator for the Company’s Pivotal Trial in Niemann-Pick Disease Type C
finance.yahoo.com - October 9 at 8:17 AM
Cyclo Therapeutics the new name for CTD holdingsCyclo Therapeutics the new name for CTD holdings
seekingalpha.com - October 4 at 4:42 PM
Cyclo Therapeutics, Inc. – The New Name for CTD Holdings.Cyclo Therapeutics, Inc. – The New Name for CTD Holdings.
finance.yahoo.com - October 4 at 4:41 PM
CTD Holdings, Inc.: CTD Holdings Receives Buy Recommendation from Frazier, Browne and Mayers Strategic Allocator, a High Net-Worth Investor JournalCTD Holdings, Inc.: CTD Holdings Receives Buy Recommendation from Frazier, Browne and Mayer's Strategic Allocator, a High Net-Worth Investor Journal
www.finanznachrichten.de - October 3 at 4:32 PM
CTD Holdings Receives Buy Recommendation from Frazier, Browne and Mayers Strategic Allocator, a High Net-Worth Investor JournalCTD Holdings Receives Buy Recommendation from Frazier, Browne and Mayer's Strategic Allocator, a High Net-Worth Investor Journal
finance.yahoo.com - October 3 at 4:32 PM
CTD Holdings Announces New Collaboration with the Chattanooga Center for Neurologic Research to Advance Alzheimer’s Disease StudyCTD Holdings Announces New Collaboration with the Chattanooga Center for Neurologic Research to Advance Alzheimer’s Disease Study
finance.yahoo.com - September 27 at 4:51 PM
CTD Holdings, Inc.: Why Did Board Insiders Recently Buy More Than 500,000 Shares of This Companys Stock?CTD Holdings, Inc.: Why Did Board Insiders Recently Buy More Than 500,000 Shares of This Company's Stock?
www.finanznachrichten.de - September 18 at 10:51 PM
Why Did Board Insiders Recently Buy More Than 500,000 Shares of This Companys Stock?Why Did Board Insiders Recently Buy More Than 500,000 Shares of This Company's Stock?
finance.yahoo.com - September 18 at 10:51 PM
CTD Holdings Announces FDA Approval of US Expanded Access Treatment Program in Niemann-Pick Disease Type CCTD Holdings Announces FDA Approval of US Expanded Access Treatment Program in Niemann-Pick Disease Type C
finance.yahoo.com - September 13 at 8:42 AM
CTD Holdings to Present at 2019 Annual Conference for NPC Patients, Families, and Health Professionals in the United KingdomCTD Holdings to Present at 2019 Annual Conference for NPC Patients, Families, and Health Professionals in the United Kingdom
finance.yahoo.com - September 11 at 9:14 AM
CTD Holdings Interview to Air on Bloomberg International on the RedChip Money ReportCTD Holdings Interview to Air on Bloomberg International on the RedChip Money Report
finance.yahoo.com - September 5 at 9:19 AM
CTD Announces New Data Presented at Annual Gathering of Patients and Families Tackling Niemann-Pick Disease Type CCTD Announces New Data Presented at Annual Gathering of Patients and Families Tackling Niemann-Pick Disease Type C
finance.yahoo.com - August 15 at 10:00 AM
CTD Holdings Announces Filing of Data From Expanded Access Program in Late Onset Alzheimer’s Disease in Support of Its Patent Application Filed In 2018CTD Holdings Announces Filing of Data From Expanded Access Program in Late Onset Alzheimer’s Disease in Support of Its Patent Application Filed In 2018
finance.yahoo.com - August 13 at 12:15 PM
CTD Announces Support and Participation at Annual Family Conference of National Niemann-Pick Disease FoundationCTD Announces Support and Participation at Annual Family Conference of National Niemann-Pick Disease Foundation
finance.yahoo.com - July 31 at 12:39 PM
CTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development ProgramCTD Holdings Scientific Advisory Board Endorses Alzheimer’s Disease as Next Indication for Company’s Trappsol® Cyclo™ Drug Development Program
finance.yahoo.com - July 18 at 11:46 AM
CTD Data Helps Fight Alzheimer’sCTD Data Helps Fight Alzheimer’s
www.baystreet.ca - July 11 at 4:05 PM
CTD Holdings Submits Application for Listing on NASDAQCTD Holdings Submits Application for Listing on NASDAQ
finance.yahoo.com - June 12 at 2:41 PM
CTD Holdings, Inc.: CTD Announces Continuation of Expanded Access Program in Single Alzheimers PatientCTD Holdings, Inc.: CTD Announces Continuation of Expanded Access Program in Single Alzheimer's Patient
www.finanznachrichten.de - June 10 at 11:50 AM
CTD Announces Continuation of Expanded Access Program in Single Alzheimers PatientCTD Announces Continuation of Expanded Access Program in Single Alzheimer's Patient
finance.yahoo.com - June 10 at 11:50 AM
CTD Holdings, Inc.: CTD Holdings Closes $7.4 Million Private PlacementCTD Holdings, Inc.: CTD Holdings Closes $7.4 Million Private Placement
www.finanznachrichten.de - May 31 at 4:29 PM
CTD Holdings Closes $7.4 Million Private PlacementCTD Holdings Closes $7.4 Million Private Placement
finance.yahoo.com - May 31 at 4:29 PM
CTD Holdings, Inc.: CTD Holdings Announces $7.2 Million Private PlacementCTD Holdings, Inc.: CTD Holdings Announces $7.2 Million Private Placement
www.finanznachrichten.de - May 31 at 11:13 AM
CTD Holdings Announces $7.2 Million Private PlacementCTD Holdings Announces $7.2 Million Private Placement
finance.yahoo.com - May 30 at 11:15 AM
CTD Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type CCTD Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type C
finance.yahoo.com - May 23 at 11:12 AM
CTD Announces Participation and Support for Upcoming Gathering of Patient-Support Organizations for Niemann-Pick Disease type CCTD Announces Participation and Support for Upcoming Gathering of Patient-Support Organizations for Niemann-Pick Disease type C
finance.yahoo.com - May 16 at 8:50 AM
CTD Announces New Expanded Access Program in the United Kingdom using Trappsol(R) Cyclo(TM) Intravenously for Niemann-Pick Disease type CCTD Announces New Expanded Access Program in the United Kingdom using Trappsol(R) Cyclo(TM) Intravenously for Niemann-Pick Disease type C
finance.yahoo.com - May 10 at 11:23 AM
CTD Holdings, Inc.: CTD Announces New Expanded Access Program in Taiwan using Trappsol Cyclo for Niemann-Pick Disease type CCTD Holdings, Inc.: CTD Announces New Expanded Access Program in Taiwan using Trappsol Cyclo for Niemann-Pick Disease type C
www.finanznachrichten.de - May 7 at 11:17 AM
CTD Announces New Expanded Access Program in Taiwan using Trappsol Cyclo for Niemann-Pick Disease type CCTD Announces New Expanded Access Program in Taiwan using Trappsol Cyclo for Niemann-Pick Disease type C
finance.yahoo.com - May 7 at 11:17 AM
CTD Holdings, Inc.: CTD Holdings Announces M. Flint Beal, MD Joins Scientific Advisory BoardCTD Holdings, Inc.: CTD Holdings Announces M. Flint Beal, MD Joins Scientific Advisory Board
www.finanznachrichten.de - April 15 at 9:21 AM
CTD Holdings Announces M. Flint Beal, MD Joins Scientific Advisory BoardCTD Holdings Announces M. Flint Beal, MD Joins Scientific Advisory Board
finance.yahoo.com - April 15 at 9:21 AM
CTD Holdings IncCTD Holdings Inc
www.bloomberg.com - March 18 at 4:40 PM
CTD Holdings, Inc.: CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo in Alzheimers DiseaseCTD Holdings, Inc.: CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo in Alzheimer's Disease
www.finanznachrichten.de - March 15 at 4:29 PM
CTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo (TM) in Alzheimers DiseaseCTD Holdings Announces Plan to Launch Clinical Trial of Trappsol (R) Cyclo (TM) in Alzheimer's Disease
finance.yahoo.com - March 14 at 11:52 AM
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: Roth IRA

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel